Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay
Julia Aulin(Uppsala University), Joachim Burman(Uppsala University), Karl Sjölin(Uppsala University Hospital), Kim Kultima(Uppsala University), Anders Svenningsson(Karolinska Institutet), Asma Al-Grety(Uppsala University), Anders Larsson(Uppsala University), Ida Erngren(Uppsala University Hospital)
Cited by 0
Related Papers
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
|Annals of Neurology|2010|347
Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes
|BMC Biology|2007|257
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
|Neurology|2004|245
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
PhenoMeNal: processing and analysis of metabolomics data in the cloud
|GigaScience|2018|147